Premium
The epileptic amygdala: Toward the development of a neural prosthesis by temporally coded electrical stimulation
Author(s) -
Cota Vinícius Rosa,
Drabowski Bruna Marcela Bacellar,
de Oliveira Jasiara Carla,
Moraes Márcio Flávio Dutra
Publication year - 2016
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/jnr.23741
Subject(s) - neuroscience , epileptogenesis , amygdala , epilepsy , stimulation , psychology , deep brain stimulation , electrical brain stimulation , anticonvulsant , kindling , brain stimulation , connectome , medicine , functional connectivity , disease , parkinson's disease
Many patients with epilepsy do not obtain proper control of their seizures through conventional treatment. We review aspects of the pathophysiology underlying epileptic phenomena, with a special interest in the role of the amygdala, stressing the importance of hypersynchronism in both ictogenesis and epileptogenesis. We then review experimental studies on electrical stimulation of mesiotemporal epileptogenic areas, the amygdala included, as a means to treat medically refractory epilepsy. Regular high‐frequency stimulation (HFS) commonly has anticonvulsant effects and sparse antiepileptogenic properties. On the other hand, HFS is related to acute and long‐term increases in excitability related to direct neuronal activation, long‐term potentiation, and kindling, raising concerns regarding its safety and jeopardizing in‐depth understanding of its mechanisms. In turn, the safer regular low‐frequency stimulation (LFS) has a robust antiepileptogenic effect, but its pro‐ or anticonvulsant effect seems to vary at random among studies. As an alternative, studies by our group on the development and investigation of temporally unstructured electrical stimulation applied to the amygdala have shown that nonperiodic stimulation (NPS), which is a nonstandard form of LFS, is capable of suppressing both acute and chronic spontaneous seizures. We hypothesize two noncompetitive mechanisms for the therapeutic role of amygdala in NPS, 1) a direct desynchronization of epileptic circuitry in the forebrain and brainstem and 2) an indirect desynchronization/inhibition through nucleus accumbens activation. We conclude by reintroducing the idea that hypersynchronism, rather than hyperexcitability, may be the key for epileptic phenomena and epilepsy treatment. © 2016 Wiley Periodicals, Inc.